Table 3.
Detailed information of 16 phenols
No | Ingredients | Diseases | Use of cell lines | Mechanism of action | References |
---|---|---|---|---|---|
1 | Gallic acid | Bladder cancer | TSGH-8301 | ↓p-ERK | Liao et al. (2018) |
2 | Carvacrol | Choriocarcinoma | JAR and JEG3 | ↓p-ERK1/2,↑p-JNK and↑p–p38 | Lim et al. (2019) |
3 | Hydroxychavicol | Colon cancer | HT-29 | ↑p-JNK and↑p–p38 | Rajedadram et al. (2021) |
4 | Ferulic acid | Lung cancer and Liver cancer | A549 and HepG2 | ↓p–p38 | Das et al. (2019) |
5 | Honokiol | Oral squamous cell carcinoma | OC2 and OCSL | ↓p-ERK, ↓p-JNK and ↓p–p38 | Huang et al. (2018) |
6 | Vanillin | Colorectal cancer | SW480 and HT-29 | ↑p–p38 | Li et al. (2021a, b, c) |
Colon cancer | HCT-116 | ↓p-ERK, ↓p-JNK and ↓p–p38 | Li et al. (2018a, b) | ||
7 | Sinapic Acid | Human neuroblastoma | SH-SY6Y | ↓p-ERK1/2,↓p-JNK and ↓p–p38 | Tungalag and Yang (2021) |
8 | Resveratrol | Pancreatic cancer | Panc-1 | ↓p-ERK and ↓p–p38 | Chen and Liu (2018) |
Gastric cancer | GC7901 | ↓RAF | Yang et al. (2018) | ||
9 | Chlorogenic acid | Lung cancer | A549 | ↑p38 | Yamagata et al. (2018) |
10 | Gingerol | Colon cancer | HCT116 | ↑p-ERK,↑p-JNK and↑p–p38 | Chen and Liu (2018) |
11 | Peperobtusin A | Lymphoma | U937 | ↑p–p38 | Shi et al. (2018) |
12 | Curcumin | Retinoblastoma | RB Y79 | ↑p-JNK and↑p–p38 | Wang et al. (2021a, b) |
Adrenocortical carcinoma | SW-13 and NCI-H295R | ↑p-JNK and↑p–p38 | Huang et al. (2021a, b) | ||
13 | Rubioncolin C | Triple negative breast cancer | MDA-MB-231 | ↑p-ERK,↑p-JNK and↑p–p38 | Li et al. (2021a, b, c) |
14 | Salvianolic acid A | B-cell lymphoma | Raji and Jeko-1 | ↑p-JNK, ↓p-ERK and ↓p–p38 | Li et al. (2021a, b, c) |
15 | Proanthocyanidins | Lung cancer | LLC and A549 | ↑p-JNK and↑p–p38 | Xu et al. (2021) |
16 | Salvianolic acid B | Osteosarcoma | MG63 | ↑p–p38 | Zeng et al. (2018a, b) |